ask="6.55"
ask_size="100"
average_daily_volume="27"
bid="2.88"
bid_size="600"
book_value="0.00"
change="+0.00"
change_from_200_day_moving_average="-8.88"
change_from_50_day_moving_average="-4.34"
change_from_52_week_high="-13.69"
change_From_52_week_low="0.00"
change_in_percent="+0.00%"
close="4.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="N/A"
high_52_weeks="17.69"
last_trade_date="3/2/2017"
last_trade_price="4.00"
last_trade_size="N/A"
last_trade_time="10:30am"
low="N/A"
low_52_weeks="4.00"
market_capitalization="4.60B"
moving_average_200_day="12.88"
moving_average_50_day="8.34"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="N/A"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-68.95%"
percent_change_from_50_day_moving_average="-52.01%"
percent_change_from_52_week_high="-77.39%"
percent_change_from_52_week_low="+0.00%"
previous_close="4.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="1150000000"
short_ratio="0.00"
stock_exchange="NCM"
symbol="TROVU"
volume="0"
weeks_range_52="4.00 - 17.69"
